These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. Smith CM; Watson DI; Michael MZ; Hussey DJ World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019 [TBL] [Abstract][Full Text] [Related]
6. Biology of Barrett's esophagus and esophageal adenocarcinoma. Wang DH; Souza RF Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):25-38. PubMed ID: 21112495 [TBL] [Abstract][Full Text] [Related]
12. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. Fassan M; Pizzi M; Battaglia G; Giacomelli L; Parente P; Bocus P; Ancona E; Rugge M J Clin Pathol; 2010 Aug; 63(8):692-6. PubMed ID: 20702469 [TBL] [Abstract][Full Text] [Related]
13. High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma. Fisher OM; Levert-Mignon AJ; Lord SJ; Botelho NK; Freeman AK; Thomas ML; Falkenback D; Wettstein A; Whiteman DC; Bobryshev YV; Lord RV Ann Surg Oncol; 2015 Jul; 22(7):2431-8. PubMed ID: 25348778 [TBL] [Abstract][Full Text] [Related]
14. Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma. Segat D; Cassaro M; Dazzo E; Cavallini L; Romualdi C; Salvador R; Vitale MP; Vitiello L; Fassan M; Rugge M; Zaninotto G; Ancona E; Baroni MD Histol Histopathol; 2010 May; 25(5):551-60. PubMed ID: 20238294 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829 [TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma. Beilstein M; Silberg D Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613 [TBL] [Abstract][Full Text] [Related]
17. Advances in understanding the pathogenesis of Barrett's esophagus. Clemons NJ; Koh SY; Phillips WA Discov Med; 2014 Jan; 17(91):7-14. PubMed ID: 24411696 [TBL] [Abstract][Full Text] [Related]